The question is unclear, however If you go to the related link (Antinuclear Antibody Test ) below you Will find detailed information on the Antinuclear Antibody Test
The acronym ANA stands for anti-nuclear antibody. When your doctor suspects you may have an autoimmune disorder, he or she will test for the presence of anti-nuclear antibodies in your blood. To perform the ANA test, serum from your blood specimen is added to microscope slides which have commercially prepared cells on the slide surface. If your serum contains antinuclear antibodies (ANA), they bind to the cells (specifically the nuclei of the cells) on the slide. A second antibody, commercially tagged with a fluorescent dye, is added to the mix of patient's serum and commercially prepared cells on the slide. The second (fluorescent) antibody attaches to the serum antibodies and cells which have bound together. When viewed under an ultraviolet microscope, antinuclear antibodies appear as fluorescent cells. If fluorescent cells are observed, the ANA test is considered positive. If fluorescent cells are not observed, the ANA test is considered negative. The ANA titer is determined by repeating the positive test with serial dilutions until the test yields a negative result. The last dilution which yields a positive result (flourescence) is the titer which gets reported. For example, if a titer performed for a positive ANA test is: 1:10 positive 1:20 positive 1:40 positive 1:80 positive 1:160 positive 1:320 negative The reported titer would be 1:160. Generally, an ANA titre of 1:80 or higher is considered positive. At least 5% of the population has a positive ANA titre with no disease activity. For those with disease activity, the ANA titre does not indicate the absolute amount of disease activity (e.g. one person with an ANA titre of 1:640 may have very little disease activity, while another with a titre of 1:320 may have significant disease activity). The ANA titre must be evaluated in the context of the individual. The ANA test by itself is not specific for any disease. Your clinical presentation, as well as tests for additional antibodies, complements and factors in your blood will also be used to determine what condition, if any, is present, and how to treat it. Source(s): http://arthritis.about.com/od/diagnostic… webmd.com medhelp.org
AnswerA complete blood count (CBC), erythrocyte sedimentation rate (ESR), C protein, rheumatoid factor (RF), and antinuclear antibody (ANA) may be done for patients with suspected rheumatoid arthritis (RA). CBC may show anemia, ESR and C protein may be elevated as a reflection of the inflammatory aspect of the disease, RF is present in 70% of RA patients, and ANA is present in 30%, the latter two reflecting the autoimmune component of the disease.
A complete blood count (CBC), erythrocyte sedimentation rate (ESR), C protein, rheumatoid factor (RF), and antinuclear antibody (ANA) may be done for patients with suspected rheumatoid arthritis (RA). CBC may show anemia; ESR and C protein may be elevated as a reflection of the inflammatory aspect of the disease. RF is present in 70% of RA patients, and ANA is present in 30%; the latter two reflect the autoimmune component of the disease.
6
Santa Ana. It was however by his own proclomation.
YES
The ANA titer is the number of times the blood sample has to be diluted before a sample remains that has no antinuclear antibodies. The first dilution is 1:40, then 1:80, then 1:160, then 1:320. The ANA number does not correlate to the level of disease activity. Many people have a positive ANA and no disease at all. In lupus, the immunofluorscent pattern is of more significance than the titer. A speckeld pattern points to the likelihood of lupus.
ANA stands for (number of) Antinuclear Antibodies. The people with elevated A.N.A. do not have lupus.
An ANA (antinuclear antibody) test is a blood test used to detect the presence of antibodies that may indicate autoimmune disorders. A reflex titer is a follow-up test that is automatically performed if the initial ANA test result is positive, measuring the concentration of these antibodies. This helps in assessing the likelihood of autoimmune diseases, such as lupus or rheumatoid arthritis, and guiding further diagnosis and treatment. A higher titer indicates a greater level of antibodies, which can correlate with disease activity.
Elevated antinuclear antibodies (ANA) can indicate various autoimmune diseases, such as lupus, rheumatoid arthritis, or Sjögren's syndrome. It can also be elevated in chronic infections, certain medications, or in individuals with a family history of autoimmune disorders. Further evaluation by a healthcare provider is needed to determine the underlying cause of the elevated ANA levels.
10 million Americans have a positive ANA. About 1.5 million Americans have lupus. Of the 1.5 million who have lupus 95-98% have a negative ANA. People are more likely to have a positive ANA as they age. Many people with a positive ANA never show any signs of autoimmune disease at all. A speckled titer can be indicative of lupus. No one can predict or even give odds about your chance of defeloping lupus.
An ANA (antinuclear antibody) pattern of homogeneous typically indicates the presence of antibodies that may be related to systemic lupus erythematosus (SLE) or other autoimmune disorders. An ANA titer of 1:1160 is considered high, suggesting a significant immune response and a higher likelihood of an underlying autoimmune condition. It is important for the patient to undergo further evaluation and testing to determine the specific diagnosis and potential implications for treatment.
A positive ANA (antinuclear antibody) screen indicates the presence of autoantibodies that may suggest an autoimmune disorder, such as lupus or rheumatoid arthritis. An ANA titer of 140, which indicates the dilution at which the antibodies are still detectable, is considered a relatively high level and may warrant further investigation. However, a positive ANA result can also occur in healthy individuals, so clinical correlation with symptoms and additional testing is essential for diagnosis. It's important to consult a healthcare provider for interpretation in the context of the patient's overall health.
ANA stands for antinuclear antibodies. About 10 million Americans have them. Many have no disease. The older you are, the more likely you are to have a positive ANA. The ANA test is a titer. The result is the number of times ones blood must be diluted in order to come up with a sample that has no autoantibodies. The autoantibodies are then tested with immunofluorescence. The resulting pattern helps determine the type of disease.
ANA, or antinuclear antibody, is an antibody in the blood that may indicate the propensity of an individual to mount an autoimmune response, which is an attack against a part of one's own body. ANA specifically targets the nucleus of a cell. While elevated ANA is common and does not necessarily indicate a disease, the more elevated the level, the more concerning for an underlying problem. We measure the level based upon the titer, which tells us how much the blood has to be diluted before the ANA can no longer be detected; titers above 1:40 are considered positive (although still low and often of no real significance). A titer of 1:647 is very high and warrants additional testing for an autoimmune disease. The classic disease associated with this is systemic lupus erythematosis (SLE, or lupus), although other diseases may involve an elevated ANA as well, such as scleroderma, Sjogren's syndrome, primary biliary cirrhosis, autoimmune hepatitis, and Raynaud's syndrome. Your symptoms sound quite suggestive of SLE. This disease can affect multiple systems throughout the body. Diagnosing it is difficult because there is no single "lupus" test and the symptoms widely vary from person to person. Fulfillment of four out of 11 possible criteria (symptoms and blood tests) strongly suggests the diagnosis. Your doctor can examine you and determine the appropriate testing to further assess for the possibility of lupus or another autoimmune disorder.
The acronym ANA stands for anti-nuclear antibody. When your doctor suspects you may have an autoimmune disorder, he or she will test for the presence of anti-nuclear antibodies in your blood. To perform the ANA test, serum from your blood specimen is added to microscope slides which have commercially prepared cells on the slide surface. If your serum contains antinuclear antibodies (ANA), they bind to the cells (specifically the nuclei of the cells) on the slide. A second antibody, commercially tagged with a fluorescent dye, is added to the mix of patient's serum and commercially prepared cells on the slide. The second (fluorescent) antibody attaches to the serum antibodies and cells which have bound together. When viewed under an ultraviolet microscope, antinuclear antibodies appear as fluorescent cells. If fluorescent cells are observed, the ANA test is considered positive. If fluorescent cells are not observed, the ANA test is considered negative. The ANA titer is determined by repeating the positive test with serial dilutions until the test yields a negative result. The last dilution which yields a positive result (flourescence) is the titer which gets reported. For example, if a titer performed for a positive ANA test is: 1:10 positive 1:20 positive 1:40 positive 1:80 positive 1:160 positive 1:320 negative The reported titer would be 1:160. Generally, an ANA titre of 1:80 or higher is considered positive. At least 5% of the population has a positive ANA titre with no disease activity. For those with disease activity, the ANA titre does not indicate the absolute amount of disease activity (e.g. one person with an ANA titre of 1:640 may have very little disease activity, while another with a titre of 1:320 may have significant disease activity). The ANA titre must be evaluated in the context of the individual. The ANA test by itself is not specific for any disease. Your clinical presentation, as well as tests for additional antibodies, complements and factors in your blood will also be used to determine what condition, if any, is present, and how to treat it. Source(s): http://arthritis.about.com/od/diagnostic… webmd.com medhelp.org
No. Approximately 10 million Americans have a positive ANA. There are about 1.5 million Americans with lupus. 95-98% of people with lupus have a positive ANA, the others do not. Most people with lupus have a positive ANA, but some do not. Many people have a positive ANA and have another autoimmune disease or no disease at all. The immunofluorescent pattern of the ANA is more significant than the titer number. Lupus usually presents with a speckled rather than homogeneous pattern. There are no definitive biomarkers for lupus.